Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Procter & Gamble Health Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500126 | NSE: PGHL

Watchlist

NSE BSE

5174.90

05-Jul-2024

Open
High
Low
Previous Close

5169.10
5198.05
5106.70
5165.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4706
242.25
5833.30
4636.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,453.32
39.16
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,208.96
5.11%
13.93

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-3.22
1.09

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-0.54
2.71

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-4.58
1.44

P:E (Median)

8 Years
5 Years
3 Years

39.54
41.45
36.98

P:BV (Average)

8 Years
5 Years
3 Years

11.23
11.23
11.25

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.80
26.70
24.61

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 313.41 304.93 2.78% 283.88 301.18 -5.74% 252.48 320.92 -21.33% 309.97 309.97 0.00%
Expenses 199.37 216.27 -7.81% 235.63 255.84 -7.90% 185.04 241.26 -23.30% 208.32 201.11 3.59%
EBITDA 114.04 88.66 28.63% 48.25 45.34 6.42% 67.44 79.66 -15.34% 101.65 108.86 -6.62%
EBIDTM 36.39% 29.08% 17.00% 15.05% 26.71% 24.82% 32.79% 35.12%
Other Income 3.28 6.05 -45.79% 2.13 5.46 -60.99% 2.27 4.97 -54.33% 5.18 4.54 14.10%
Interest 0.15 0.18 -16.67% 0.20 0.17 17.65% 0.15 0.21 -28.57% 0.19 0.23 -17.39%
Depreciation 5.77 6.48 -10.96% 7.16 6.50 10.15% 6.84 5.89 16.13% 6.92 8.23 -15.92%
PBT 111.40 88.05 26.52% 22.83 44.13 -48.27% 62.72 78.53 -20.13% 99.72 104.94 -4.97%
Tax 29.07 22.48 29.31% 6.05 14.31 -57.72% 16.16 19.34 -16.44% 27.65 28.14 -1.74%
PAT 82.33 65.57 25.56% 16.78 29.82 -43.73% 46.56 59.19 -21.34% 72.07 76.80 -6.16%
PATM 26.27% 21.50% 5.91% 9.90% 18.44% 18.44% 23.25% 24.78%
EPS 49.60 39.50 25.57% 10.11 17.96 -43.71% 28.05 35.66 -21.34% 43.42 46.27 -6.16%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14
Net Sales 1,159.74 1,151.26 1,229.62 1,114.41 1,008.73 1,355.86 1,288.08 698.13 992.56 939.50 867.49 Net Sales Growth -6.25% -6.37% 10.34% 10.48% -25.60% 5.26% 84.50% -29.66% 5.65% 8.30% Cost Of Goods Sold 331.47 330.56 361.84 339.80 312.12 431.44 269.36 236.94 411.54 437.19 405.06 Gross Profit 828.27 820.70 867.78 774.61 696.61 924.42 1,018.72 461.19 581.02 502.31 462.43 GP Margin 71.42% 71.29% 70.57% 69.51% 69.06% 68.18% 79.09% 66.06% 58.54% 53.47% 53.31% Total Expenditure 828.36 845.26 904.94 846.73 762.71 1,041.52 1,077.93 627.50 876.99 856.06 808.58 Power & Fuel Cost - 8.50 12.88 14.70 12.97 19.09 12.23 11.68 14.96 15.14 9.89 % Of Sales - 0.74% 1.05% 1.32% 1.29% 1.41% 0.95% 1.67% 1.51% 1.61% 1.14% Employee Cost - 215.16 206.17 167.56 153.66 182.93 131.27 109.88 154.23 123.17 113.56 % Of Sales - 18.69% 16.77% 15.04% 15.23% 13.49% 10.19% 15.74% 15.54% 13.11% 13.09% Manufacturing Exp. - 113.33 126.07 132.01 125.61 121.02 72.37 69.14 58.36 70.81 73.68 % Of Sales - 9.84% 10.25% 11.85% 12.45% 8.93% 5.62% 9.90% 5.88% 7.54% 8.49% General & Admin Exp. - 99.67 87.16 60.88 51.79 153.86 94.39 82.02 141.55 116.30 130.45 % Of Sales - 8.66% 7.09% 5.46% 5.13% 11.35% 7.33% 11.75% 14.26% 12.38% 15.04% Selling & Distn. Exp. - 52.65 74.49 109.45 87.41 118.96 115.66 90.72 81.36 84.61 70.44 % Of Sales - 4.57% 6.06% 9.82% 8.67% 8.77% 8.98% 12.99% 8.20% 9.01% 8.12% Miscellaneous Exp. - 25.39 36.33 22.33 19.15 14.22 382.65 27.12 14.99 8.84 70.44 % Of Sales - 2.21% 2.95% 2.00% 1.90% 1.05% 29.71% 3.88% 1.51% 0.94% 0.63% EBITDA 331.38 306.00 324.68 267.68 246.02 314.34 210.15 70.63 115.57 83.44 58.91 EBITDA Margin 28.57% 26.58% 26.40% 24.02% 24.39% 23.18% 16.31% 10.12% 11.64% 8.88% 6.79% Other Income 12.86 15.63 18.39 13.19 18.10 69.96 722.34 83.68 24.41 23.31 20.33 Interest 0.69 0.72 0.77 0.42 0.80 0.00 0.00 0.00 0.00 0.00 0.00 Depreciation 26.69 27.40 28.10 27.08 30.04 29.45 21.12 19.12 24.81 23.42 12.68 PBT 296.67 293.51 314.20 253.37 233.28 354.85 911.37 135.19 115.17 83.33 66.56 Tax 78.93 72.34 84.73 60.85 56.48 100.77 79.21 58.28 36.04 29.77 23.34 Tax Rate 26.61% 26.47% 26.97% 24.02% 24.21% 28.40% 8.63% 38.29% 31.29% 35.73% 35.07% PAT 217.74 200.98 229.47 192.52 176.80 254.08 838.72 93.91 79.13 53.56 43.22 PAT before Minority Interest 217.74 200.98 229.47 192.52 176.80 254.08 838.72 93.91 79.13 53.56 43.22 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.77% 17.46% 18.66% 17.28% 17.53% 18.74% 65.11% 13.45% 7.97% 5.70% 4.98% PAT Growth -5.90% -12.42% 19.19% 8.89% -30.42% -69.71% 793.11% 18.68% 47.74% 23.92% EPS 131.17 121.07 138.23 115.98 106.51 153.06 505.25 56.57 47.67 32.27 26.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14
Shareholder's Funds 538.24 750.89 616.49 703.71 906.34 1,540.11 733.26 663.82 591.55 554.30 Share Capital 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 16.60 Total Reserves 513.11 726.45 592.61 683.24 887.80 1,523.51 716.66 647.22 574.95 537.70 Non-Current Liabilities 840.55 803.00 713.63 723.42 667.16 494.83 430.50 398.93 395.03 390.13 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 866.67 818.79 732.68 739.90 681.10 510.01 455.27 413.06 395.71 392.30 Current Liabilities 625.30 679.08 607.73 550.68 538.62 547.69 352.19 300.50 538.89 259.76 Trade Payables 167.00 237.04 172.08 178.91 123.96 91.42 83.28 75.10 65.55 43.77 Other Current Liabilities 38.22 42.49 42.32 36.64 94.51 78.02 82.21 68.23 61.03 59.62 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 420.08 399.55 393.33 335.13 320.15 378.25 186.70 157.17 412.31 156.37 Total Liabilities 2,004.09 2,232.97 1,937.85 1,977.81 2,112.12 2,582.63 1,515.95 1,363.25 1,525.47 1,204.19 Net Block 126.60 141.72 109.06 100.96 97.92 99.76 115.07 110.66 131.73 109.71 Gross Block 223.32 263.07 241.11 214.90 199.57 185.60 191.51 143.96 271.28 231.72 Accumulated Depreciation 96.72 121.35 131.32 113.94 101.65 61.39 51.22 24.82 139.55 122.01 Non Current Assets 1,073.48 1,061.69 953.98 938.96 847.28 693.45 636.69 613.07 579.47 581.00 Capital Work in Progress 5.89 32.49 40.60 39.15 21.45 17.35 8.90 29.98 7.00 27.63 Non Current Investment 0.00 0.00 0.00 0.00 3.30 3.82 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 939.09 885.23 801.72 795.90 724.61 572.52 511.59 470.50 435.76 434.13 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 1.13 1.93 4.98 9.53 Current Assets 930.61 1,171.28 983.87 1,038.85 1,264.84 1,889.18 879.26 750.18 946.00 623.19 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 69.97 27.78 42.28 23.87 Inventories 109.11 134.94 115.21 118.37 134.11 113.35 157.74 163.94 166.86 177.32 Sundry Debtors 85.33 115.71 83.44 59.81 95.27 66.17 122.66 107.04 126.57 104.53 Cash & Bank 244.36 440.22 324.53 468.91 639.09 1,243.42 278.18 279.27 188.42 163.95 Other Current Assets 491.81 13.73 7.95 6.36 396.37 466.24 250.71 172.15 421.87 153.52 Short Term Loans & Adv. 467.64 466.68 452.74 385.40 388.61 435.63 221.21 145.19 390.46 136.78 Net Current Assets 305.31 492.20 376.14 488.17 726.22 1,341.49 527.07 449.68 407.11 363.43 Total Assets 2,004.09 2,232.97 1,937.85 1,977.81 2,112.12 2,582.63 1,515.95 1,363.25 1,525.47 1,204.19

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14
Cash From Operating Activity 228.29 236.01 169.52 247.26 235.37 -130.39 53.66 107.04 83.47 4.95 PBT 273.32 314.20 253.37 233.28 354.85 1,137.57 152.19 115.18 83.33 66.56 Adjustment 52.27 41.49 27.31 40.89 -12.16 -913.68 7.66 14.87 16.32 21.10 Changes in Working Capital -12.12 -30.02 -47.30 41.22 -5.73 -50.26 -46.66 30.11 15.64 -48.53 Cash after chg. in Working capital 313.47 325.67 233.38 315.39 336.96 173.63 113.19 160.16 115.29 39.13 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -85.18 -89.66 -63.86 -68.13 -101.59 -304.02 -59.53 -53.12 -31.82 -34.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -6.87 -21.50 -25.54 -32.27 164.64 1,269.72 -47.63 -74.97 -67.84 10.57 Net Fixed Assets 66.35 -13.85 -27.66 -33.03 -18.07 -2.54 -26.47 104.34 -18.93 -53.19 Net Investments 0.00 0.00 0.00 3.30 0.52 66.15 -42.19 14.50 -18.41 0.42 Others -73.22 -7.65 2.12 -2.54 182.19 1,206.11 21.03 -193.81 -30.50 63.34 Cash from Financing Activity -418.11 -98.47 -288.63 -386.63 -883.41 -30.12 -21.98 -14.98 -11.92 -16.62 Net Cash Inflow / Outflow -196.69 116.04 -144.65 -171.64 -483.40 1,109.21 -15.95 17.09 3.71 -1.10 Opening Cash & Equivalents 435.42 319.40 464.05 635.69 1,119.09 9.88 26.27 9.18 5.47 6.57 Closing Cash & Equivalent 238.73 435.44 319.40 464.05 635.69 1,119.09 10.32 26.27 9.18 5.47

Financial Ratios

Standalone

Right to Left

Description Jun 24 Jun 23 Jun 22 Jun 21 Jun 20 Dec 18 Dec 17 Dec 16 Dec 15 Dec 14
Book Value (Rs.) 319.10 447.62 366.99 421.59 544.82 927.78 441.72 399.89 356.36 333.92 ROA 9.49% 11.00% 9.83% 8.65% 10.82% 40.93% 6.52% 5.48% 3.92% 4.67% ROE 31.58% 33.94% 29.41% 22.04% 20.79% 73.79% 13.44% 12.61% 9.35% 8.02% ROCE 42.52% 46.07% 38.45% 29.08% 29.01% 80.76% 21.79% 18.35% 14.54% 12.36% Fixed Asset Turnover 5.18 5.27 5.17 4.87 7.04 6.83 4.24 4.96 3.87 4.19 Receivable days 29.14 27.36 22.20 28.06 21.73 26.75 58.92 41.40 43.30 38.34 Inventory Days 35.37 34.37 36.19 45.68 33.31 38.41 82.51 58.63 64.49 66.90 Payable days 223.07 206.35 188.51 177.09 43.33 49.94 53.71 33.69 25.86 20.54 Cash Conversion Cycle -158.56 -144.61 -130.12 -103.36 11.71 15.22 87.72 66.33 81.93 84.70 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 380.61 409.05 604.26 292.60 0.00 0.00 0.00 0.00 0.00 0.00

Top Investors:

nippon life india trustee ltd-a/c nippon india sma

icici prudential mnc fund

lici asm non par

investor education and protection fund (iepf)

Annual Reports:

News Update:

Procter&Gamble Healt - Quarterly Results
21st Aug 2024, 16:05 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback